FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump Sends Room Into Roaring Laughter Responding to Kid Who Didn’t Want Coal for Christmas

Booker says Gabbard ‘endangering’ NJ with remarks on radical Islam, heavily-Muslim city; deputy responds

Kentucky congressman announces death of longtime aide and campaign manager

JonBenet Ramsey case could benefit from new DNA technology as police renew commitment

Unreliable: The Epstein Tipster Claiming Trump Was a Rapist Also Claimed a Man Fired by Hillary Clinton Tried to Frame Him for the 1995 OKC Bombing

Trump launches Christmas night airstrikes in Nigeria and more top headlines

Trump matches Biden’s first year of US attorney nominees despite high-profile setbacks

House lawmakers reflect on their memorable moments in Congress

Trump Announces Christmas Day Strikes on Islamic Terrorists Involved in Nigerian Christian Genocide

Nebraska grandfather killed in ‘freak accident’ at McDonald’s drive-thru

Ultra High Level Democrat Influencer Calls for Violence Against ‘Dead Man Walking’ Trump on Christmas Eve – Calls on People to ‘Put Him to Sleep’

Santa with CCW gets pulled over, tells Ohio deputy ‘you got to protect yourself’ during festive traffic stop

Nonprofit uses underwater technology to search for missing service members

Fox News ‘Antisemitism Exposed’ Newsletter: UN bigot out at Georgetown

Kim Jong Un swipes at South Korea’s progress building a nuclear submarine while inspecting his own

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”